Share
    NEW SEARCH RETURN TO SEARCH RESULTS
Number: GOG 0255 Principal Investigator: Mutch, David
Title: A Phase II Randomized Double-Blind Trial Of A Polyvalent Vaccine-KLH Conjugate (NSC 748933 IND# 14384) + OPT-821 Versus OPT-821 In Patients With Epithelial Ovarian, Fallopian Tube, Or Peritoneal Cancer Who Are In Second Or Third Complete Remission
Phase: II Disease Site: Multiple Sites
Participating Site(s):
 
Main Campus
Map and Directions
 
Contact: 800-600-3606 or info@ccadmin.wustl.edu
Description:
The purpose of this research is to study a vaccine treatment for patients with ovarian, fallopian tube, or peritoneal cancer, and see if the vaccine may be able to delay or prevent your cancer from returning again.
 
More Information:
Internal Protocol Documents (requires Siteman administrative database password)